Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
08/2014
08/12/2014US8802123 Endosseous implant
08/12/2014US8802116 Poloxamer emulsion preparations
08/12/2014US8802114 Pharmaceutical compositions of iron for oral administration
08/12/2014US8802113 Extracellular matrix cancer vaccine adjuvant
08/12/2014US8802107 VEGF antagonist formulations for intravitreal administration
08/12/2014US8802102 Formulation of human antibodies for treating TNF-α associated disorders
08/12/2014US8802101 Formulation of human antibodies for treating TNF-α associated disorders
08/12/2014US8802100 Formulation of human antibodies for treating TNF-alpha associated disorders
08/12/2014US8802087 Pharmaceutical compositions of lipase-containing products, in particular of pancreation
08/12/2014US8802075 Bi-functional co-polymer use for opthalmic and other topical and local applications
08/12/2014US8802062 Apparatus and method for whitening teeth
08/12/2014US8802058 Pharmaceutical compositions and methods for administering the same
08/12/2014US8802054 Method for characterizing the oxidative stress protective capacity of an antioxidative substance
08/12/2014US8801847 Microcrystalline cellulose compositions
08/12/2014US8801700 Osmotic delivery systems and piston assemblies for use therein
08/12/2014US8801694 Intravesical drug delivery device
08/12/2014US8801690 Method and composition for hyperthermally treating cells
08/12/2014US8801648 Ocular implant with anchor and methods thereof
08/12/2014CA2739751C Pharmaceutical compositions comprising hydromorphone and naloxone
08/12/2014CA2680433C Novel composition based on cholest-4-ene-3-one oxime
08/12/2014CA2668775C Melt-processed imatinib dosage form
08/12/2014CA2652226C Use of a hydrophilic matrix comprising a polyacrylic acid derivative, a cellulose ether and a disintegrant for the manufacture of a medicament for treating female genital disorders
08/12/2014CA2631677C Amphoteric liposome formulation
08/12/2014CA2625557C Stable, durable granules with active agents
08/12/2014CA2623112C Method for producing ultrafine submicronic suspensions
08/12/2014CA2612511C Permeant delivery system and methods for use thereof
08/12/2014CA2589453C Pharmaceutical formulations
08/12/2014CA2579732C Tablets with site time-controlled gastrointestinal release of active ingredient
08/12/2014CA2570507C Calcium peroxyphosphates and use thereof in dental compositions
08/12/2014CA2559050C Multilayered transdermal drug delivery device
08/12/2014CA2540038C Aerosol formulations comprising formoterol fumarate dihydrate, a propellant,ethanol and optionally a steroid,where the formoterol fumarate dihydrate has a water content of 4.8-4.28% by weight
08/12/2014CA2539051C Delayed release dosage forms
08/12/2014CA2528545C Process for the manufacture of stable shaped particles consisting of estradiol and cholesterol
08/12/2014CA2492047C Short duration depot formulations
08/07/2014WO2014121291A2 Nanoparticle drug delivery systems
08/07/2014WO2014121232A1 Artificial tears comprising sodium hyaluronate and carboxymethylcellulose
08/07/2014WO2014121224A2 Biodegradable iron oxide nanoparticle gel for tumor bed therapy
08/07/2014WO2014121000A1 Minimally invasive surgery, including vascular closure, and associated sealants
08/07/2014WO2014120982A1 Solid dispersion formulation of an antiviral compound
08/07/2014WO2014120981A1 Combination formulation of two antiviral compounds
08/07/2014WO2014120866A1 Sustained release formulations for the treatment of intraocular pressure or glaucoma
08/07/2014WO2014120587A1 Ureteral stent with drug-releasing structure
08/07/2014WO2014118809A1 Pharmaceutical composition with linezolid
08/07/2014WO2014118721A1 Pharmaceutical oral solid dosage forms comprising valsartan and nebivolol
08/07/2014WO2014118527A1 Topical composition comprising dantrolene and/or azumolene
08/07/2014WO2014118522A1 Carbon nanostructures for ocular tissue reinforcement
08/07/2014WO2014118438A1 Composition for binding aldehydes in the mouth
08/07/2014WO2014118355A1 Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives
08/07/2014WO2014118112A1 Pharmaceutical composition comprising erlotinib hydrochloride
08/07/2014WO2014118090A1 Periodontal disease treatment
08/07/2014WO2014117999A1 Compositions and methods for treating chronic inflammation and inflammatory diseases
08/07/2014WO2014087175A3 Droplet assembly by 3d printing
08/07/2014WO2014081392A8 Composition and method for respiratory delivery of dye for visualisation of eye
08/07/2014WO2014064410A3 Pharmaceutical composition comprising tiotropium and a hydrofluoroalkane
08/07/2014WO2013183068A4 Surfactant-copolymer complexes useful for sustained drug release
08/07/2014US20140221978 Balloon Catheter Systems for Delivery of Dry Drug Delivery Vesicles to a Vessel in the Body
08/07/2014US20140221972 Method for treating glaucoma
08/07/2014US20140221961 Insertable medical device for delivering nano-carriers of mitomycin (and its analogues) to a target site, and methods for preparing and using the same
08/07/2014US20140221942 A Device for the Transdermal Delivery of Alkaline Compounds that are Susceptible to Degradation in Their Free Base Form
08/07/2014US20140221922 Absorbable crystalline polyether-ester-urethane-based bioactive luminal liner compositions
08/07/2014US20140221906 Patch system for the treatment of warts and method for same
08/07/2014US20140221501 Therapeutic foam
08/07/2014US20140221490 Methods of treating pain
08/07/2014US20140221489 Infusion and Injection Solution of Levodopa
08/07/2014US20140221488 Injectable Melphalan Compositions Comprising a Cyclodextrin Derivative and Methods of Making and Using the Same
08/07/2014US20140221449 Dividable galenical form allowing modified release of the active ingredient
08/07/2014US20140221447 Formulation for preventing or reducing bleeding at a surgical site
08/07/2014US20140221445 Aqueous ophthalmic solutions of phentolamine and medical uses thereof
08/07/2014US20140221425 Quinolyl-containing Hydroxamic Acid Compound and Preparation Method Thereof, and Pharmaceutical Composition Containing This Compound and Use Thereof
08/07/2014US20140221416 Tamper Resistant Pharmaceutical Formulations
08/07/2014US20140221413 Preoperative treatment of post operative pain
08/07/2014US20140221407 Use and application of a pharmaceutical composition containing a mixture of natural-origin heterocyclical guanidine, for cosmetology, wound healing, focal dystonia and muscular spasm- related clinical pathologies
08/07/2014US20140221326 Ophthalmologic irrigation solutions and method
08/07/2014US20140221320 Topical minocycline ointment for suppression of allergic skin responses
08/07/2014US20140221307 In-situ gel forming compositions
08/07/2014US20140221306 Ophthalmic solution comprising diquafosol, method for producing the same, and method for inhibiting formation of insoluble precipitate
08/07/2014US20140221274 Low impurity content caspofungin preparation, method for preparing same, and use thereof
08/07/2014US20140220676 Method and Medicament for Inhibiting the Expression of a Given Gene
08/07/2014US20140220156 Method of promoting mucosal reciliation
08/07/2014US20140220149 Method for prevention and treatment of reflux injury in the aerodigestive tract and laryngopharynx caused by pepsin
08/07/2014US20140220148 Diaminooxidase-containing pharmaceutical compositions
08/07/2014US20140220147 Pharmaceutical composition comprising factor vii encapsulated in micelles
08/07/2014US20140220146 Use of opioid antagonists for treating urinary retention
08/07/2014US20140220145 Method for stimulating retinal response using photoactive devices
08/07/2014US20140220144 Orally disintegrating tablet compositions of lamotrigine
08/07/2014US20140220140 Compositions of efavirenz
08/07/2014US20140220138 Enhanced nitric oxide delivery and uses thereof
08/07/2014US20140220136 System and method for delivering protease inhibitors
08/07/2014US20140220134 Method for treating diabetes with extended release formulation of glp-1 receptor agonists
08/07/2014US20140220129 Compositions Comprising S-Adenosylmethionine and a Gallic Acid Ester
08/07/2014US20140220128 Solid Dosage Form
08/07/2014US20140220127 Reduction of opioid blood fluctuations
08/07/2014US20140220126 Abuse-deterrent pharmaceutical compositions for controlled release
08/07/2014US20140220124 Combination tablet with chewable outer layer
08/07/2014US20140220123 Pharmaceutical compositions comprising niacin and a process for their preparation
08/07/2014US20140220121 Novel formulation of diclofenac
08/07/2014US20140220120 Crystal entecavir, crystal entecavir formulation and methods for the preparation thereof
08/07/2014US20140220119 Capsules Containing High Doses of Levodopa for Pulmonary Use
08/07/2014US20140220118 Solid formulations of ospemifene
08/07/2014US20140220116 Methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells
1 ... 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 ... 2991